Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C8H12N2O2 |
| Molecular Weight | 168.1931 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 2 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C=NCCCCCCN=C=O
InChI
InChIKey=RRAMGCGOFNQTLD-UHFFFAOYSA-N
InChI=1S/C8H12N2O2/c11-7-9-5-3-1-2-4-6-10-8-12/h1-6H2
| Molecular Formula | C8H12N2O2 |
| Molecular Weight | 168.1931 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 2 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Synthesis of beta-cyclodextrin and starch based polymers for sorption of azo dyes from aqueous solutions. | 2008-02 |
|
| Transport behavior of n-alkane penetrants into castor oil based polyurethane-polyester nonwoven fabric composites. | 2007-06-25 |
|
| The effect of monomers on the formulation of polymeric nanocapsules based on polyureas and polyamides. | 2007-04-20 |
|
| Isosteric heats of sorption of 1-naphthol and phenol from aqueous solutions by beta-cyclodextrin polymers. | 2007-03-01 |
|
| New biodegradable thermogelling copolymers having very low gelation concentrations. | 2007-02 |
|
| Determination of pulmonary irritant threshold concentrations of hexamethylene-1,6-diisocyanate (HDI) prepolymers by bronchoalveolar lavage in acute rat inhalation studies according to TRGS 430. | 2007-02 |
|
| Cytokeratin autoantibodies: useful serologic markers for toluene diisocyanate-induced asthma. | 2006-12-31 |
|
| Diisocyanate asthma and gene-environment interactions with IL4RA, CD-14, and IL-13 genes. | 2006-12 |
|
| Evaluation of antibody binding to diisocyanate protein conjugates in a general population. | 2006-09 |
|
| Modeling dermal exposure--an illustration for spray painting applications. | 2006-09 |
|
| Dermal, inhalation, and internal exposure to 1,6-HDI and its oligomers in car body repair shop workers and industrial spray painters. | 2006-09 |
|
| Subacute inhalation exposure of rats to 1,6-hexamethylene diisocyanate with recovery period. | 2006-08 |
|
| Assessing isocyanate exposures in polyurethane industry sectors using biological and air monitoring methods. | 2006-08 |
|
| Tape-strip sampling for measuring dermal exposure to 1,6-hexamethylene diisocyanate. | 2006-06 |
|
| Circulating autoantibodies in patients with aspirin-intolerant asthma: an epiphenomenon related to airway inflammation. | 2006-06 |
|
| Determination of airborne isocyanates generated during the thermal degradation of car paint in body repair shops. | 2006-06 |
|
| Airborne hexamethylene diisocyanate and particulate matter exposures during fire/rescue vehicle ladder finishing operations. | 2006-03 |
|
| PEO-PPO-PEO-based poly(ether ester urethane)s as degradable reverse thermo-responsive multiblock copolymers. | 2006-03 |
|
| Materials for peripheral nerve regeneration. | 2006-01-05 |
|
| Polycondensation of dicarboxylic acids and diols in water catalyzed by surfactant-combined catalysts and successive chain extension. | 2006-01 |
|
| The human macrophage response during differentiation and biodegradation on polycarbonate-based polyurethanes: dependence on hard segment chemistry. | 2005-12 |
|
| Application of cross-linked beta-cyclodextrin polymer for adsorption of aromatic amino acids. | 2005-11-03 |
|
| Poly(ester urethane)s consisting of poly[(R)-3-hydroxybutyrate] and poly(ethylene glycol) as candidate biomaterials: characterization and mechanical property study. | 2005-09-13 |
|
| Chemical analysis of 2,4-toluene diisocyanate, 1,6-hexamethylene diisocyanate and isophorone diisocyanate in petrolatum patch-test preparations. | 2005-09 |
|
| Validation of a solvent-free sampler for the determination of low molecular weight aliphatic isocyanates under thermal degradation conditions. | 2005-09 |
|
| Construction of a biomimetic zwitterionic interface for monitoring cell proliferation and apoptosis. | 2005-08-30 |
|
| Biodegradable cationic PEG-PEI-PBLG hyperbranched block copolymer: synthesis and micelle characterization. | 2005-07 |
|
| DNA strand breaks in the lymphocytes of workers exposed to diisocyanates: indications of individual differences in susceptibility after low-dose and short-term exposure. | 2005-06 |
|
| Chemical modification of poly(vinyl chloride) resin using poly(ethylene glycol) to improve blood compatibility. | 2005-06 |
|
| Gene expression profiling in mouse lung following polymeric hexamethylene diisocyanate exposure. | 2005-05-15 |
|
| Designing biodegradable multiblock PCL/PLA thermoplastic elastomers. | 2005-05 |
|
| Effect of soft segment length on properties of fluorinated polyurethanes. | 2005-04-10 |
|
| Preparation of ZnO nanoparticles in a reverse micellar system and their photoluminescence properties. | 2005-04-01 |
|
| Solvent-free sampling with di-n-butylamine for monitoring of isocyanates in air. | 2005-04 |
|
| Glutathione protects human airway proteins and epithelial cells from isocyanates. | 2005-03 |
|
| The increase in denaturation temperature following cross-linking of collagen is caused by dehydration of the fibres. | 2005-02-18 |
|
| Quantitative determination of hexamethylene diisocyanate (HDI), 2,4-toluene diisocyanate (2,4-TDI) and 2,6-toluene diisocyanate (2,6-TDI) monomers at ppt levels in air by alkaline adduct coordination ionspray tandem mass spectrometry. | 2005-02 |
|
| Polycarbonate-urethane hard segment type influences esterase substrate specificity for human-macrophage-mediated biodegradation. | 2005 |
|
| Physical, mechanical and degradation properties, and schwann cell affinity of cross-linked chitosan films. | 2005 |
|
| Ferrocenoyl piperazide as derivatizing agent for the analysis of isocyanates and related compounds using liquid chromatography/electrochemistry/mass spectrometry (LC/EC/MS). | 2004-12 |
|
| Chemical graft polymerization of sulfobetaine monomer on polyurethane surface for reduction in platelet adhesion. | 2004-11-25 |
|
| Urinary hexane diamine to assess respiratory exposure to hexamethylene diisocyanate aerosol: a human inhalation study. | 2004-10-12 |
|
| Allergic contact dermatitis from isocyanates among sculptors. | 2004-09 |
|
| Preparation of Y2O3:Eu3+ nanoparticles in reverse micellar systems and their photoluminescence properties. | 2004-08-15 |
|
| Porcine collagen crosslinking, degradation and its capability for fibroblast adhesion and proliferation. | 2004-08 |
|
| Platelet adhesive resistance of polyurethane surface grafted with zwitterions of sulfobetaine. | 2004-07-01 |
|
| Determination of technical grade isocyanates used in the production of polyurethane plastics. | 2004-07 |
|
| Isocyanate vapor-induced antigenicity of human albumin. | 2004-06 |
|
| Cytokine adsorptive property of various adsorbents in immunoadsorption columns and a newly developed adsorbent: an in vitro study. | 2004 |
|
| Surface characterization and platelet adhesion studies of aliphatic polyurethanes grafted by fluorocarbon oligomers: effect of fluorocarbon chain length and carboxylic acid group. | 2002-01 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:08:12 GMT 2025
by
admin
on
Mon Mar 31 19:08:12 GMT 2025
|
| Record UNII |
0I70A3I1UF
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
HEXAMETHYLENE DIISOCYANATE
Created by
admin on Mon Mar 31 19:08:12 GMT 2025 , Edited by admin on Mon Mar 31 19:08:12 GMT 2025
|
PRIMARY | |||
|
0I70A3I1UF
Created by
admin on Mon Mar 31 19:08:12 GMT 2025 , Edited by admin on Mon Mar 31 19:08:12 GMT 2025
|
PRIMARY | |||
|
822-06-0
Created by
admin on Mon Mar 31 19:08:12 GMT 2025 , Edited by admin on Mon Mar 31 19:08:12 GMT 2025
|
PRIMARY | |||
|
53578
Created by
admin on Mon Mar 31 19:08:12 GMT 2025 , Edited by admin on Mon Mar 31 19:08:12 GMT 2025
|
PRIMARY | |||
|
DTXSID4024143
Created by
admin on Mon Mar 31 19:08:12 GMT 2025 , Edited by admin on Mon Mar 31 19:08:12 GMT 2025
|
PRIMARY | |||
|
13192
Created by
admin on Mon Mar 31 19:08:12 GMT 2025 , Edited by admin on Mon Mar 31 19:08:12 GMT 2025
|
PRIMARY | |||
|
6134
Created by
admin on Mon Mar 31 19:08:12 GMT 2025 , Edited by admin on Mon Mar 31 19:08:12 GMT 2025
|
PRIMARY | |||
|
11687
Created by
admin on Mon Mar 31 19:08:12 GMT 2025 , Edited by admin on Mon Mar 31 19:08:12 GMT 2025
|
PRIMARY | |||
|
0I70A3I1UF
Created by
admin on Mon Mar 31 19:08:12 GMT 2025 , Edited by admin on Mon Mar 31 19:08:12 GMT 2025
|
PRIMARY | |||
|
53216
Created by
admin on Mon Mar 31 19:08:12 GMT 2025 , Edited by admin on Mon Mar 31 19:08:12 GMT 2025
|
PRIMARY | |||
|
212-485-8
Created by
admin on Mon Mar 31 19:08:12 GMT 2025 , Edited by admin on Mon Mar 31 19:08:12 GMT 2025
|
PRIMARY | |||
|
1428547
Created by
admin on Mon Mar 31 19:08:12 GMT 2025 , Edited by admin on Mon Mar 31 19:08:12 GMT 2025
|
PRIMARY | RxNorm |